Market Overview

The Global Parkinson’s Disease Therapeutics Market was valued at USD 5,844.6 million in 2023 and is expected to reach USD 15,319.0 million by 2031 while growing at a CAGR of 12.8% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global parkinson’s disease therapeutics market growth. While there is no cure for Parkinson's disease, treatments exist to alleviate symptoms and preserve quality of life. These treatments encompass supportive therapies like physiotherapy, medication, and, in certain cases, surgical interventions.

Continuous advancements in drug delivery systems, including extended-release formulations and wearable devices for symptom management, alongside rising awareness and diagnosis, propel market growth. However, obstacles such as the high cost of treatment and limited efficacy of current treatments impede further market expansion.

Furthermore, the global parkinson’s disease therapeutics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Drug Class Analysis

The Global Parkinson’s Disease Therapeutics Market is segmented among Carbidopa-Levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics, and Others, based on Drug Class. In 2023, Carbidopa-Levodopa accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Distribution Channel Analysis

The Global Parkinson’s Disease Therapeutics Market is segmented among Hospital Pharmacy, Specialty Pharmacy, and Online Pharmacy, based on Distribution Channel. In 2023, Specialty Pharmacy accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Parkinson’s Disease Therapeutics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Cerevel Therapeutics, Novartis AG, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc., GlaxoSmithKline plc. (GSK), AbbVie, Inc., H. Lundbeck A/S, Amneal Pharmaceuticals LLC., and Supernus Pharmaceuticals, Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Parkinson’s Disease Therapeutics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Parkinson’s Disease Therapeutics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Parkinson’s Disease Therapeutics Market Segmentation, By Drug Class

• Global Parkinson’s Disease Therapeutics Market Share Analysis, By Drug Class

• Global Parkinson’s Disease Therapeutics Market Growth Analysis, By Drug Class

• Global Parkinson’s Disease Therapeutics Market Trends, By Drug Class

o Carbidopa-Levodopa

o Dopamine Agonists

o MAO-B Inhibitors

o COMT Inhibitors

o Anticholinergics

o Others

6. Global Parkinson’s Disease Therapeutics Market Segmentation, By Distribution Channel

• Global Parkinson’s Disease Therapeutics Market Share Analysis, By Distribution Channel

• Global Parkinson’s Disease Therapeutics Market Growth Analysis, By Distribution Channel

• Global Parkinson’s Disease Therapeutics Market Trends, By Distribution Channel

o Hospital Pharmacy

o Specialty Pharmacy

o Online Pharmacy

7. Global Parkinson’s Disease Therapeutics Market Segmentation, By Region

• Global Parkinson’s Disease Therapeutics Market Share Analysis, By Region

• Global Parkinson’s Disease Therapeutics Market Growth Analysis, By Region

• Global Parkinson’s Disease Therapeutics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Cerevel Therapeutics*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Novartis AG

• Teva Pharmaceutical Industries Ltd

• Merck & Co., Inc.

• GlaxoSmithKline plc. (GSK)

• AbbVie, Inc.

• H. Lundbeck A/S

• Amneal Pharmaceuticals LLC.

• Supernus Pharmaceuticals, Inc

*Similar analysis will be provided for each company listed above.